TVGNW
Tevogen Bio Holdings Inc. NASDAQ$0.04
Mkt Cap $7.4M
52w Low $0.03
29.9% of range
52w High $0.04
50d MA $0.04
200d MA $0.05
P/E (TTM)
0.0x
EV/EBITDA
-2.2x
P/B
—
Debt/Equity
-0.4x
ROE
—
P/FCF
-4.4x
RSI (14)
—
ATR (14)
—
Beta
-0.30
50d MA
$0.04
200d MA
$0.05
Avg Volume
102.3K
About
Tevogen Bio Holdings Inc. operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Its lead investigational precision T cell product, TVGN 489, is designed to address the unmet need of acute-risk COVID-19 patients, as well as a subset of patients suffering from long COVID. The company is based in Warren, New …
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 25, 2026 | AMC | -1.50 | -1.50 | +0.0% | 0.04 | -5.2% | -0.7% | +5.2% | +1.6% | -11.0% | -13.1% | — |
| Nov 14, 2025 | AMC | -0.06 | -0.03 | +52.0% | 0.05 | -1.3% | +0.0% | -0.4% | -1.1% | +0.0% | -1.3% | — |
| Aug 14, 2025 | AMC | -0.05 | -0.03 | +40.2% | 0.06 | +32.6% | -0.3% | -0.3% | +2.3% | +1.7% | -0.2% | — |
| May 14, 2025 | AMC | -0.05 | -0.06 | -31.8% | 0.06 | -3.3% | +0.0% | -1.6% | -10.2% | -17.4% | +18.3% | — |
Data updated apr 28, 2026 11:29pm
· Source: massive.com